NexusTrade Loading NexusTrade… Taking too long? Reload this page

About eXoZymes Inc. Common Stock (EXOZ)

eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Ticker
EXOZ
Exchange
XNAS
Sector
Healthcare
Industry
Biotechnology

Company profile updated October 11, 2026.

Stored market snapshot

As of October 9, 2026. Daily closing data may differ from the live quote shown in the dashboard.

Stored daily close (USD)
$5.25
Company market capitalization (USD)
$48,727,134.75
Price / book
13.33×

Research EXOZ

Compare the company’s price history and fundamentals in the dashboard. Explore disclosed trading and ownership activity in these research collections: